脑转录组变化与蛋白质O-GlcNAcylation急剧增加相关,以及神经退行性疾病的影响
Margaret B Bell1, Mariame S Kane1, Xiaosen Ouyang1
1Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Journal of neurochemistry
|January 17, 2025
概括
抑制O-GlcNAcase (OGA) 增加了O-GlcNAcylation,可能治疗阿尔茨海默病 (AD). 用Thiamet G (TG) 的急性治疗改变了基因表达,揭示了对AD和衰老相关的途径的影响.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 基因组学就是基因组学.
背景情况:
- 药理上抑制O-GlcNAcase (OGA) 增强了蛋白质O-GlcNAcylation,这是阿尔茨海默病 (AD) 探索的一种策略,以减少tau和粉样β病理.
- 了解增加O-GlcNAcylation的广泛影响对于评估OGA抑制剂作为神经退行性疾病治疗药物至关重要.
研究的目的:
- 在正常小鼠中使用Thiamet G (TG) 调查OGA抑制对大脑转录组的急性影响.
- 为了识别由急性OGA抑制引起的基因表达特征和受影响的途径.
主要方法:
- 正常的小鼠接受了OGA抑制剂Thiamet G (TG) 或盐水治疗3小时.
- 使用NovaSeq PE 150进行了全脑mRNA测序,以分析差异性基因表达.
- 使用定量PCR (qPCR) 验证特定基因表达的变化,例如AMPK子单元Prkab2.
主要成果:
- 与盐水相比,TG治疗导致1234个显著差异地表达的基因.
- 上调的基因在通常在AD下调的路径中得到丰富,而下调的基因包括细胞粘附路径和通常在AD和衰老中上调的基因.
- 无论是急性还是慢性TG治疗,都显示出蛋白自酸化和激酶活性通路的升高调节,以及细胞粘附和星细胞标记物的降低调节. 线粒体基因在急性和慢性治疗之间显示了相反的趋势.
结论:
- 由TG引起的急性OGA抑制显著改变了大脑的转录组,影响了与AD和衰老相关的途径.
- 该研究强调了OGA抑制剂对生物能量的潜在下游影响,这可能会影响它们在AD治疗中的疗效.
- 研究结果提供了关于OGA抑制机制及其在治疗神经退行性疾病方面的潜在局限性的见解.
相关概念视频
Oligosaccharide Assembly
2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.8K
Regulation of Expression at Multiple Steps
868
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
868


